Finance

Lists
PSNL:NASDAQ
Personalis Inc
$16.32
-0.85%
(-0.14) 1D
$16.31
-0.06% (-0.010)
After hours
Closed: Sep 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PSNL...
Open
$16.22
High
$16.48
Low
$16.00
Mkt. cap
1.74B
Avg. vol.
3.21M
Volume
1.67M
52-wk high
$18.89
52-wk low
$4.96
EPS
-$1.09
Beta
2.31
Shares outstanding
106.80M
No. of employees
260
Open
$16.22
High
$16.48
Low
$16.00
Mkt. cap
1.74B
Avg. vol.
3.21M
Volume
1.67M
52-wk high
$18.89
52-wk low
$4.96
EPS
-$1.09
Beta
2.31
Shares outstanding
106.80M
No. of employees
260
News stories
From web sources and news partners
About Personalis Inc
CEO-
Employees260
Founded2011
Headquarters-
SectorHealth care
Websitepersonalis.com
Analyst ratings
Based on 6 analysts giving stock ratings to PSNL in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PSNL in the last 3 months.
Highest
Current $16.32
$18.00 (+10.29%)
Average
$15.95 (-2.27%)
Lowest
$13.00 (-20.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Hold
Downgraded
$16.25
-0.4%
08/24/2026
John Wilkin
Craig-Hallum
Hold
Downgraded
$16.25
-0.4%
08/24/2026
Thomas Flaten
Lake Street
Hold
Maintained
$16.25
-0.4%
08/21/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/06/2026
Ryan MacDonald
Needham
Hold
Maintained
-
-
08/06/2026
Mark Massaro
BTIG
Buy
Maintained
$16.25
-0.4%
07/20/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$18.00
+10.3%
07/15/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Reiterated
$13.00
-20.3%
07/09/2026
Jacob Stephan
Lake Street
Buy
Maintained
$11.00
-32.6%
05/20/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$13.00
-20.3%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
14.50M
17.34M
15.47M
22.36M
Cost of goods sold
12.58M
15.44M
15.19M
17.61M
Cost of revenue
12.58M
15.44M
15.19M
17.61M
Research and development expenses
12.17M
13.07M
14.54M
16.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.03M
14.09M
17.90M
22.00M
Operating expense
25.20M
27.17M
32.44M
38.33M
Total operating expenses
37.79M
42.61M
47.63M
55.95M
Operating income
-23.29M
-25.27M
-32.16M
-33.59M
Other non operating income
-
-142.00K
-
-9.00K
EBT including unusual items
-21.65M
-23.80M
-30.02M
-31.68M
EBT excluding unusual items
-21.65M
-23.80M
-30.02M
-31.68M
Income tax expense
3.00K
9.00K
16.00K
5.00K
Effective tax rate
-0.01%
-0.04%
-0.05%
-0.02%
Other operating expenses
-
-
-
-
Net income
-21.65M
-23.81M
-30.03M
-31.68M
Net profit margin
-149.38%
-137.28%
-194.11%
-141.71%
Earnings per share
-0.24
-0.26
-0.29
-0.30
Interest and investment income
1.68M
1.57M
2.17M
1.97M
Interest expense
-64.00K
-65.00K
-47.00K
-37.00K
Net interest expenses
1.62M
1.50M
2.12M
1.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.82M
-22.80M
-29.79M
-31.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps